Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Alzamend Neuro, Inc. (ALZN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsApr-30-23Apr-30-22Apr-30-21Apr-30-20Apr-30-19
   10-K10-K10-K10-KS-1/A
OPERATING EXPENSES       
Research and development  7.45.21.31.1 
General and administrative  7.47.13.63.41.3
    Total operating expenses  14.912.35.04.4 
    Loss from operations  -14.9-12.3-5.0-4.4-5.0
   
OTHER INCOME (EXPENSE), NET       
Interest expense  0.00.0-0.1  
Gain on extinguishment of debt   0.00.1  
    Total other income (expense), net  0.00.0-0.10.0 
    NET LOSS  -14.9-12.4-5.0-4.4-4.9
   
Basic net loss per common share  ($0.15)($0.14) ($0.06)($0.08)
Diluted net loss per common share  ($0.15)($0.14) ($0.06)($0.08)
   
Basic weighted average common shares outstanding  97.589.172.771.358.8
Diluted weighted average common shares outstanding  97.589.1   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy